New Antimicrobial Resistance Campaign Launched

Antibiotic resistance is growing and is one of the great health threats of our time. As a result, the Royal Pharmaceutical Society (RPS) is launching a new collaborative campaign at its conference in September to help achieve the necessary reduction in inappropriate prescribing of antibiotics  You can help the organisation build this future campaign by [...]

By |2017-07-19T09:21:42+00:00July 19th, 2017|Community Pharmacy, Hospital Pharmacy|Comments Off on New Antimicrobial Resistance Campaign Launched

Darzi Fellowship to Use Community Pharmacy for the First Time

A Darzi Fellowship for 2017 / 18 has been approved for UCLH Cancer Collaborative to work with LloydsPharmacy to evaluate the implications of delivering subcutaneous hormonal injections for breast and prostate cancer via a community pharmacist model.  This is the first time that a Darzi Fellowship in Clinical Leadership will involve community pharmacy. The output [...]

By |2017-07-19T09:20:26+00:00July 19th, 2017|Community Pharmacy|Comments Off on Darzi Fellowship to Use Community Pharmacy for the First Time

First Treatment Approval for Sickle Cell Disease in Nearly 20 Years

The US Food and Drug Administration has approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder. ‘Endari is the first treatment approved for patients with sickle cell disease in almost 20 years,’ commented Richard Pazdur, MD, Acting Director of [...]

By |2017-07-19T09:19:20+00:00July 19th, 2017|Industry News|Comments Off on First Treatment Approval for Sickle Cell Disease in Nearly 20 Years